John F. Chin
Director/Board Member chez ANTENGENE CORPORATION LIMITED
Fortune : 233 244 $ au 31/03/2024
Postes actifs de John F. Chin
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ANTENGENE CORPORATION LIMITED | Director/Board Member | 18/08/2020 | - |
| Corporate Officer/Principal | 18/08/2020 | - | |
Aventis Pharmaceuticals, Inc.
 Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01/10/1998 | - |
Antengene Corporation Co., Ltd.
 Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Antengene Corporation Co., Ltd. operates as a holding company. It engages in clinical development of drug candidates. The company was founded on June 15, 2016 and is headquartered in Shanghai, China. | Director/Board Member | - | - |
| Corporate Officer/Principal | - | - |
Historique de carrière de John F. Chin
Anciens postes connus de John F. Chin
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CELGENE | Corporate Officer/Principal | 01/01/2005 | 01/01/2020 |
Formation de John F. Chin
| Pepperdine University | Masters Business Admin |
| University of Arizona | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Chine | 3 |
Opérationnelle
| Corporate Officer/Principal | 4 |
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ANTENGENE CORPORATION LIMITED | Health Technology |
| Entreprise privées | 3 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Aventis Pharmaceuticals, Inc.
Aventis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aventis Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The company was founded in 1950 and is headquartered in Bridgewater, NJ. | Health Technology |
Antengene Corporation Co., Ltd.
Antengene Corporation Co., Ltd. Pharmaceuticals: MajorHealth Technology Antengene Corporation Co., Ltd. operates as a holding company. It engages in clinical development of drug candidates. The company was founded on June 15, 2016 and is headquartered in Shanghai, China. | Health Technology |
- Bourse
- Insiders
- John F. Chin
- Expérience
